The present invention relates AI based smart system for the early detection of omicron and covid-19 symptoms.

Prior Art:

The whole world is currently facing the health crisis in the form of novel corona virus (2019-nCoV) outbreak and every country is facing the challenges such as testing, quarantining and treating patient affected by corona virus. Chinese public health authorities on 31 December 2019 reported Severe Acute Respiratory Syndrome (SARS) like pneumonia cases of unidentified etiology in the city of Wuhan, Hubei Province, China which was later on identified as a novel corona virus (2019-nCoV) being the causative agent of this outbreak, now known as corona virus disease 2019 (COVID-19). The virus, 2019-nCoV is a novel strain of corona virus, not identified previously in humans. The initial outburst of COVID19 in Wuhan spread briskly and greatly affected other parts of China. The spread was so rapid that it took the shape of epidemic in no time with coverage in several other countries.

WO/2021/211940METHODS FOR TREATING A COMPLEMENT MEDIATED DISORDER CAUSED BY VIRUSES The present disclosure relates to, inter alia, a method of treating a complement mediated disorder caused by a virus, e.g., corona virus; Dengue virus (DENY); Ross River vims (RRV) and/or influenza virus (flu) by administering an effective amount of a complement modulator, such as, e.g., C5 inhibitor, such as eculizumab or an eculizumab variant or a C5a inhibitor such as olendalizumab (ALXN1007) or a variant thereof, to the subject. In addition, the present disclosure relates to, inter alia, a method of treating human patients inflicted with severe coronavirus disease-2019 (severe COVID-19) who is undergoing treatment with eculizumab. The method includes measuring a level of circulating component C5b-9 (membrane attack complex), in the patient's blood sample to titrate an effective eculizumab dose for the treatment of COVID-19.

WO/2021/236721METHODS FOR PREVENTING, REVERSING OR TREATING A COVID-19 INFECTION: Covid-19 is caused by a highly transmissible novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or a variant thereof. Current available therapeutic modalities have significant efficacy issues. Described herein are methods of preventing, reversing, and/or treating a Covid19 infection by administering an inhibitor of CHI3L1.

WO/2021/188906NOVEL MRNA-BASED COVID-19 MULTIVALENT VACCINE AND METHODS OF SCALED PRODUCTION OF THE SAME The inventive technology includes a novel immunostimulatory RNA vaccine for the COVID-19 coronavirus. In one preferred aspect, the inventive technology includes a novel mRNA sequence encoding at least one antigenic peptide or protein comprising or consisting of a COVID-19 coronavirus protein or a fragment or variant thereof.

WO/2021/243974FUSION PROTEIN OF SARS-COV-2 AND VACCINE COMPOSITION THEREOF: A fusion protein of SARSCoV-2 and a vaccine composition thereof. The fusion protein and the vaccine composition containing the fusion protein can induce a specific immune response for SARS-CoV-2 to achieve the purposes of inhibiting replication of SARS-CoV2, inhibiting transmission of SARS-CoV-2, or preventing common strains and variant strains of SARS-CoV-2 from colonizing in the body of a host; and the fusion protein and the vaccine composition containing the fusion protein can effectively prevent and/or treat Corona Virus Disease 2019 (COVID-19). The fusion protein can use a genetic engineering technology for mass recombinant expression, so that the elapsed time is short, and large-scale production can be facilitated.

113337639METHOD FOR DETECTING COVID-19 BASED ON MNGS AND APPLICATION OF METHOD : The invention provides a method for detecting COVID-19 based on mNGS and application of the method. According to the method, a multiple genome specific reverse transcription primer group of COVID-19 is designed and prepared, so that the reverse transcription efficiency of RNA of COVID-19 is improved, the aerosol pollution problem is reduced, and meanwhile, the enrichment capacity of different variant virus nucleotide sequences is improved.

111662389FUSION PROTEIN OF SARS-COV-2, AND VACCINE COMPOSITION OF FUSION PROTEIN: The invention belongs to the technical field of biology, and particularly relates to a fusion protein of SARSCoV-2, and a vaccine composition of the fusion protein. The fusion protein and the prepared vaccine composition containing the fusion protein overcome the defects of poor immunogenicity and the like of subunit vaccines, can induce the specific immune response aiming at SARS-CoV-2, and achieve the purposes of inhibiting the replication of SARS-CoV-2, inhibiting the spread of SARS-CoV2 or preventing the settlement of SARS-CoV-2 common strains and variant strains in SARS-CoV-2 host bodies. The fusion protein and the vaccine composition containing the fusion protein can effectively prevent and/or treat novel coronavirus pneumonia (Corona Virus Disease 2019, COVID-19). The fusion protein can be recombined and expressed in large quantities by the aid of the genetic engineering technology, the consumed time is short, and the large scale production can be facilitated.
Objective of the invention

The primary object of the present invention is AI based smart system for the early detection of omicron and covid-19 symptoms.

Summary of the invention:

Accordingly following invention is AI based smart system for the early detection of omicron and covid-19 symptoms.

According to an embodiment, the system comprises An AI based sensor unit, wherein IOT based sensor unit is connected to AI based temperature sensor, wherein AI based sensor unit is used to sense the physical parameters of the patient.

According to an embodiment, which is used by a authored person or computer to monitor the patient and inform a local controlling body to isolate the omicron and covid-19 variant suspected patient from the society.

Detailed description of invention:

The following description includes the preferred best mode of one embodiment of the present invention. It will be clear from this description of the invention that the invention is not limited to these illustrated embodiments but that the invention also includes a variety of modifications and embodiments thereto. Therefore, the present description should be seen as illustrative and not limiting. While the invention is susceptible to various modifications and alternative constructions, it should be understood, that there is no intention to limit the invention to the specific form disclosed, but, on the contrary, the invention is to cover all modifications, alternative constructions, and equivalents falling within the spirit and scope of the invention as defined in the claims.

In any embodiment described herein, the open-ended terms "comprising," "comprises,” and the like (which are synonymous with "including," "having” and "characterized by") may be replaced by the respective partially closed phrases "consisting essentially of," consists essentially of," and the like or the respective closed phrases "consisting of," "consists of, the like.

The present invention is AI based smart system for the early detection of omicron and covid-19 symptoms.

Figure 1 shows the exemplary representation of AI based smart system for the early detection of omicron and covid-19 symptoms. Although the present disclosure has been described with the purpose of two smart frameworks for providing privacy and protection in block chain based private transactions using artificial intelligent approach, it should be appreciated that the same has been done merely to illustrate the invention in an exemplary manner and to highlight any other purpose or function for which explained structures or configurations could be used and is covered within the scope of the present disclosure.

AI based smart system for the early detection of omicron and covid-19 symptoms, the system comprises An AI based sensor unit, wherein IOT based sensor unit is connected to AI based temperature sensor, wherein AI based sensor unit is used to sense the physical parameters of the patient.

AI based an oxygen measuring unit is used to measure the oxygen level in the patient, wherein the Light sensor the device will monitor the SpO2 (oxygen level) of each patient.

AI based a piezoelectric sensor unit is used to detect the breathing rate of the individual.

AI based a Pulse rate sensor are placed on a stand which towards a person entering in the premises. The temperature sensor is used to sense temperature, the Pulse rate sensor is used to measure the heartbeat of the patient entering in the premises.

A central control unit is used to process the information received from the AI based sensor unit and the visual oxygen measuring unit , wherein the center unit comprises an AI based algorithm to process the information with incorporating all the patient health data and health factor, health data and bio signals , with the current condition of the patient.

The central control unit process the information received from the AI based piezoelectric sensor, the temperature sensor, the visual oxygen measuring unit, and send alerting signal to an alarm or a mobile computing unit, which is used by a authored person or computer to monitor the patient and inform a local controlling body to isolate the omicron and covid-19 variant suspected patient from the society.

The central control unit is microcontroller based central control unit. The central control unit comprises memory, a communication unit and an associated electronic circuit. The central control unit sent the result of measurement of health factor, health data and is in glass to a display unit.

The figures and the foregoing description give examples of embodiments. Those skilled in the art will appreciate that one or more of the described elements may well be combined into a single functional element. Alternatively, certain elements may be split into multiple functional elements. Elements from one embodiment may be added to another embodiment.

For example, order of processes described herein may be changed and are not limited to the manner described herein. Moreover, the actions of any block diagram need not be implemented in the order shown; nor do all of the acts need to be necessarily performed. Also, those acts that are not dependent on other acts may be performed in parallel with the other acts. The scope of embodiments is by no means limited by these specific examples.

Although implementations of the invention have been described in a language specific to structural features and/or methods, it is to be understood that the appended claims are not necessarily limited to the specific features or methods described. Rather, the specific features and methods are disclosed as examples of implementations of the invention.

Additional advantages and modification will readily occur to those skilled in art. Therefore, the invention in its broader aspect is not limited to specific details and representative embodiments shown and described herein. Accordingly various modifications may be made without departing from the spirit or scope of the general invention concept as defined by the appended claims and their equivalents.

While the invention has been described and illustrated with reference to certain particular embodiments thereof, those skilled in the art will appreciate that various adaptations, changes, modifications, substitutions, deletions, or additions of procedures and protocols may be made without departing from the spirit and scope of the invention.

We Claim:

1. This invention analyzes AI based smart system for the early detection of omicron and covid-19 symptoms.

2. According to an embodiment, the system comprises An AI based sensor unit, wherein IOT based sensor unit is connected to AI based temperature sensor, wherein AI based sensor unit is used to sense the physical parameters of the patient.

3. According to an embodiment, the central control unit is microcontroller based central control unit.

4. According to an embodiment, the central control unit sent the result of measurement of health factor, health data.

5. According to an embodiment, which is used by an authored person or computer to monitor the patient and inform a local controlling body to isolate the omicron and covid-19 variant suspected patient from the society.